Universe Pharmaceuticals Effective Feb.13 Dual-Class Structure with 1.8B Class A, 200M Class B Shares
Universe Pharmaceuticals’ dual-class share structure becomes effective on February 13, 2026 after all implementation conditions were met. The amendment authorizes US$20,000 in share capital split into 1.8 billion Class A and 200 million Class B ordinary shares, with Class A continuing to trade under the UPC symbol.
1. Effective Date Announcement
Universe Pharmaceuticals announced that all conditions for its dual-class share structure have been satisfied and that the structure will become effective on the Nasdaq Capital Market on February 13, 2026.
2. Authorized Share Capital Amendment
The company amended and restated its memorandum and articles of association to authorize US$20,000 of share capital divided into 1,800,000,000 Class A ordinary shares and 200,000,000 Class B ordinary shares, each with a par value of US$0.00001.
3. Trading Continuity
Beginning with trading on February 13, 2026, Class A Ordinary Shares will continue to trade on Nasdaq under the symbol UPC and retain the existing CUSIP G9442G138 to ensure uninterrupted market access.
4. Company Profile
Headquartered in Ji’an, Jiangxi, China, Universe Pharmaceuticals produces and distributes traditional Chinese medicine derivatives, biomedical drugs, medical instruments and dietary supplements across 30 provinces targeting elderly health and wellness.